Stockscreener 앱 받기
102.67
0.59%
0.60
시간 외 거래:
105.40
2.73
+2.66%
전일 마감가:
$102.07
열려 있는:
$104.12
하루 거래량:
1.95M
Relative Volume:
0.75
시가총액:
$13.33B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-24.21
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
-1.44%
1개월 성능:
+8.80%
6개월 성능:
+108.30%
1년 성능:
+195.37%
1일 변동 폭
$102.20
$105.01
1주일 범위
$100.21
$106.00
52주 변동 폭
$29.91
$112.42
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
102.67 | 13.26B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
575.91 | 215.01B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.53 | 159.87B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
700.55 | 56.23B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
140.60 | 39.54B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.63 | 37.85B | 15.90B | 1.28B | 2.21B | 7.2842 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-09-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 재개 | Wells Fargo | Overweight |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Guardant Health (GH) Sees Analyst Rating Update from Leerink Par - GuruFocus
Analyst JP Morgan Raises Price Target for Guardant Health (GH) | - GuruFocus
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Guardant Health (GH) Receives Raised Price Target from Wells Far - GuruFocus
Guardant Health (GH): Reassessing Valuation After a Sharp Share Price Recovery - Yahoo Finance
Nikko Asset Management Americas Inc. Raises Stake in Guardant Health, Inc. $GH - MarketBeat
Castleark Management LLC Acquires New Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Will Guardant Health Inc stock deliver strong dividend growthTake Profit & Step-by-Step Swing Trade Plans - moha.gov.vn
Eventide Asset Management LLC Sells 107,775 Shares of Guardant Health, Inc. $GH - MarketBeat
GeneDx and Guardant Health named as BTIG’s top picks for 2026 - Investing.com Canada
GH: Analyst Mark Massaro Raises Price Target for Guardant Health | GH Stock News - GuruFocus
Osterweis Capital Management Inc. Lowers Stock Position in Guardant Health, Inc. $GH - MarketBeat
Darya Chudova Sells 13,664 Shares of Guardant Health (NASDAQ:GH) Stock - MarketBeat
Guardant Health (NASDAQ:GH) Director Sells $131,250.00 in Stock - MarketBeat
Guardant Health announces proposed $300 million offering of convertible senior notes due 2033 - MSN
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN
Citigroup Raises Price Target for GH to $135, Maintains Buy Rati - GuruFocus
Guardant Health Forms Collaboration With Trial Library to Increase US Access to Cancer Clinical Trials - marketscreener.com
HighVista Strategies LLC Has $1.47 Million Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (Nasdaq: GH) links 1M-patient data to Trial Library's 320-clinic network - Stock Titan
Have Guardant Health Insiders Been Selling Stock? - simplywall.st
Guardant Health Insider Sold Shares Worth $10,505,474, According to a Recent SEC Filing - marketscreener.com
Guardant Health director Talasaz sells $10.5 million in shares By Investing.com - Investing.com South Africa
Guardant Health director Talasaz sells $10.5 million in shares - Investing.com
Insider Sell: Kumud Kalia Sells 2,000 Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health, Inc. $GH Position Lowered by Blue Water Life Science Advisors LP - MarketBeat
Jump Financial LLC Buys New Position in Guardant Health, Inc. $GH - MarketBeat
Global ESR1 Mutated Metastatic Breast Cancer Diagnostics - openPR.com
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy - pharmiweb.com
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases New Holdings in Guardant Health, Inc. $GH - MarketBeat
Hood River Capital Management LLC Has $12.79 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Italian hospital launches on-site liquid biopsy testing with Guardant Health - Investing.com Canada
Guardant Health, Inc. $GH Shares Bought by Invesco Ltd. - MarketBeat
JPMorgan Chase & Co. Decreases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Insider Sold Shares Worth $3,241,621, According to a Recent SEC Filing - marketscreener.com
Guardant Health Insider Sold Shares Worth $8,288,742, According to a Recent SEC Filing - marketscreener.com
Guardant Health Insider Sold Shares Worth $3,066,817, According to a Recent SEC Filing - marketscreener.com
Guardant Health (NASDAQ:GH) Insider Chris Freeman Sells 31,452 Shares - MarketBeat
Insider Sell Alert: Chris Freeman Sells 31,452 Shares of Guardan - GuruFocus
Guardant Health (GH) director Clark sells $3.07 million in stock By Investing.com - Investing.com Australia
Guardant Health: chief commercial officer sells $3.24 million in stock By Investing.com - Investing.com Australia
Guardant Health: chief commercial officer sells $3.24 million in stock - Investing.com India
Guardant Health CFO Bell sells $8.29 million in shares By Investing.com - Investing.com Nigeria
Guardant Health CFO Bell sells $8.29 million in shares - Investing.com
Freenome inks deals to list stock and raise $330M - MedTech Dive
Hsbc Holdings PLC Grows Position in Guardant Health, Inc. $GH - MarketBeat
Why Guardant Health (GH) Is Down 5.9% After Big Q3 Beat And Major Capital Raise – And What's Next - Yahoo Finance
Guardant Health (NASDAQ:GH) Trading Down 4.7%Time to Sell? - MarketBeat
Norges Bank Purchases New Position in Guardant Health, Inc. $GH - MarketBeat
Extending cancer prevention’s reach - Fast Company
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
0.32%
자본화:
|
볼륨(24시간):